Linus Health, founded in 2019, is a Boston-based digital health company at the forefront of transforming brain health globally. Adopting a proactive approach, they leverage advanced neuroscience, clinical expertise, and artificial intelligence to revolutionize how cognitive and brain disorders are detected and managed.
Their digital platform is lauded for its ability to enable early detection, provide healthcare providers with actionable insights, and furnish individuals with personalized action plans. This comprehensive offering positions Linus Health as a pivotal player in the Health Care and Health and Wellness industries, with a mission to prolong and enhance lives through better brain health.
The company attracted significant attention from investors, securing a $55.00M Series B investment on 06 July 2021 from Morningside Venture Investments. With their innovative solutions, Linus Health supports key sectors, including research institutions, life sciences companies, and healthcare organizations, marking it as a promising prospect for future investment and growth.